Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032
Overview
The Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a 11,764.88 USD Million by 2032 and is projected to grow at a CAGR of 87.38% from 2025 to 2032.
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market 2018-2032 USD Million
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 367.75 USD Million
- Projected Market Size (2032): 11,764.88 USD Million
- CAGR (2025-2032): 87.38%
Key Findings of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market
- The Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market was valued at 367.75 USD Million in 2024.
- The Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market is likely to grow at a CAGR of 87.38% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Small Molecule in Drug Type Segment accounted for the largest share of the market with a revenue of 294.26 USD Million
- The fastest growing segment Novel Drug Candidates in Application Segment grew Fastest with a CAGR of 99.13% during the forecast period from 2024 to 2032.
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Scope
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
- Large Molecule
- Small Molecule
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
- Services
- Software
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 367.75 USD Million |
| Market Value in 2032 | 11,764.88 USD Million |
| CAGR (2025-2032) | 87.38% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End Use,Indication,Application,Drug Type,Technology,Offering |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 367.75 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 115.53 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032, By End Use
- Contract Research Organizations is the largest segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 185.49 USD Million in the year 2024.
- Contract Research Organizations is the Fastest growing segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 91.85 % in forecast period 2025-2032.
-
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Indication
- Immuno-Oncology is the largest segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 143.98 USD Million in the year 2024.
- Immuno-Oncology is the Fastest growing segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 90.53 % in forecast period 2025-2032.
-
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Application
- Novel Drug Candidates is the largest segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 124.63 USD Million in the year 2024.
- Novel Drug Candidates is the Fastest growing segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 99.13 % in forecast period 2025-2032.
-
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Drug Type
- Small Molecule is the largest segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 294.26 USD Million in the year 2024.
- Small Molecule is the Fastest growing segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 88.02 % in forecast period 2025-2032.
-
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Technology
- Machine Learning (ML) is the largest segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 206.03 USD Million in the year 2024.
- Machine Learning (ML) is the Fastest growing segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 89.51 % in forecast period 2025-2032.
-
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Offering
- Software is the largest segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 224.75 USD Million in the year 2024.
- Services is the Fastest growing segment in Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 83.61 % in forecast period 2025-2032.
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Scope
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
- Large Molecule
- Small Molecule
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
- Services
- Software
Frequently Asked Questions
Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.